Effective vaccines dramatically changed the course of the COVID-19 pandemic, preventing illness, reducing disease severity, and saving millions of lives. However, five years later, SARS-CoV-2 is still ...

Researchers have developed EVE-Vax, an AI tool that forecasts viral mutations and designs test proteins to guide next-generation vaccines. The breakthrough could allow scientists to build vaccines ...

Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...

Evaxion's sophisticated AI Immunology platform aims to outperform competitors in vaccine development, in both oncology and infectious diseases indications. The company has already established three ...

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text -; the genetic code. That code contains instructions ...

Immunology has undergone a revolution thanks to vaccinations. Systems immunology integrates various experimental and computational approaches to comprehend the intricate interactions between the ...

A joint research team of the Korea Advanced Institute of Science and Technology (KAIST) and domestic biotechnology firm ...

As COVID-19 continues to spread throughout the country and the world, EpiVax, a biotechnology company based in Providence, is currently leading collaborative efforts to design a vaccine against the ...

Intramuscular prime/intranasal boost vaccination protocol reduces LAIV shedding. (A) Schematic representation of the experimental design. Red points on the timeline indicate the time points of blood ...

Researchers have created an AI tool called EVE-Vax that can predict and design viral proteins likely to emerge in the future. For SARS-CoV-2, panels of these “designer” proteins triggered similar ...